Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "LA"

8967 News Found

Jubilant Ingrevia receives EIR from USFDA for Unit-1 at Bharuch
Drug Approval | June 28, 2024

Jubilant Ingrevia receives EIR from USFDA for Unit-1 at Bharuch

This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative


Aster DM Healthcare achieves NABH Digital Standards' Platinum Certification for Aster CMI Hospital
News | June 27, 2024

Aster DM Healthcare achieves NABH Digital Standards' Platinum Certification for Aster CMI Hospital

Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation


Shilpa Medicare Bio Analytical unit gets
Drug Approval | June 27, 2024

Shilpa Medicare Bio Analytical unit gets "No Action Indicated" classification from USFDA

This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies


Imfinzi improved event-free survival and overall survival for bladder cancer
Clinical Trials | June 26, 2024

Imfinzi improved event-free survival and overall survival for bladder cancer

First immunotherapy regimen before and after surgery to extend survival in bladder cancer


GlaxoSmithKline Pharmaceuticals appoints GoApptiv as super stockist
News | June 25, 2024

GlaxoSmithKline Pharmaceuticals appoints GoApptiv as super stockist

This tie-up will have no impact on any other brands of the company


Arkema grants technology license to Seqens to manufacture PEKK for sale in medical implantable applications
News | June 25, 2024

Arkema grants technology license to Seqens to manufacture PEKK for sale in medical implantable applications

PEKK is a high-performance polymer family used in aerospace and other demanding markets


Cipla gets 6 observations from USFDA for Goa facility
Drug Approval | June 24, 2024

Cipla gets 6 observations from USFDA for Goa facility

The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time


MediPharm Labs acquires advanced medical cannabis delivery method technology from Remidose Aerosols
News | June 24, 2024

MediPharm Labs acquires advanced medical cannabis delivery method technology from Remidose Aerosols

Transaction is non-dilutive, with 100% performance-based payment through a royalty model


CCRAS to organize national consultative meet on ‘Research Priority Settings in Traditional Medicine’ in collaboration with WHO
Policy | June 24, 2024

CCRAS to organize national consultative meet on ‘Research Priority Settings in Traditional Medicine’ in collaboration with WHO

The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India